290: Biotech layoffs, slumping stocks, and a 2024 preview

Biotech startups are laying off employees and adjusting strategies due to a tough market. Major biotech stories in 2024 include data readouts and FDA decisions. The impact of the JP Morgan conference on biotech stocks is discussed along with the future of the industry. Specific topics covered include a drug for fatty liver disease, Eli Lilly's Alzheimer's treatment, biomulicar condensates, and the challenges of funding and generating value in biotech.